Control of fecal peritoneal infection in mice by colony-stimulating factors

Journal of Infectious Diseases

Volumn 174, Issue 4, 1996, Pages 790-799

  Barsig, Johannes ^b   Bundschuh, Daniela Sophie ^b   Hartung, Thomas ^b   Bauhofer, Artur ^b   Sauer, Achim ^b   Wendel, Albrecht ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; COLONY STIMULATING FACTOR; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MYELOPEROXIDASE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM COLONY; COLONY FORMING UNIT; CONTROLLED STUDY; FECES; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL;

EID: 0029813083     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.4.790     Document Type: Article

References (10)

1. Moore MAS. The clinical use of colony stimulating factors. Annu Rev Immunol 1991;9:159-91.
2. Weite K, Platzer L, Gabrilove JL, Levi E, Mertelsmann R, Moore MAS. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Med Sci 1985;82:1526-30.
3. Morstyn G, Campbell L, Souza LM, et al. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988;1:667-72.
4. Molineux G, Pojda Z, Hampson IN, Lord BI, Dexter TM. Transplantation potential of peripheral blood stem cells induced by granulocyte colonystimulating factor. Blood 1990;76:2153-8.
5. Weaver CH, Buckner CD, Longin K, et al. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993; 82:1981-4.
6. Cannistra SA, Vellenga E, Groshek P, Rambaldi A, Griffin JD. Human granulocyte-monocyte colony-stimulating factor and interleukin-3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood 1988;71:672-6.
7. Wing EJ, Magge DM, Whiteside TL, Kaplan SS, Shadduck RK. Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor-α and interferon in cancer patients. Blood 1989;73:643-6.
8. Tiegs G, Barsig J, Matiba B, Uhlig S, Wendel A. Potentiation by granulocyte-macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice. J Clin Invest 1994;93:2616-22.
9. Goergen I, Hartung T, Leist M, et al. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-α. J Immunol 1992;149:918-24.
10. Santucci L, Fiorucci S, di Matteo FM, Morelli A. Role of tumor necrosis factor-α release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology 1995;108:393-401.